Owner Allergan, Inc.

Inventors Leblond, Bertrand; Beausoleil, Eric; Chauvignac, Cedric; Yang, Rong; Donello, John E.; Taverne, Thierry

Agent Davies Collison Cave

Pub. Number AU-A-2009212519

PCT Pub. Number WO2009/100095

Priority 61/026,178 05.02.08 US; 12/364,930 03.02.09 US

Filing date 4 February 2009

Wipo publication date 13 August 2009

C07D 207/10 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 233/00 (2006.01) Carboxylic acid amides

C07C 311/00 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 207/20 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 277/04 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 295/185 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms